Carregant...
Acute liver failure after changing oral anticoagulant from apixaban to rivaroxaban
Rivaroxaban is a commonly used anticoagulant agent for treatment and prevention of thromboembolism. There are case reports demonstrating an association between its use and drug-induced liver injury. However, this has not been reported in a patient who previously tolerated apixaban. An 88-year-old ma...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094353/ https://ncbi.nlm.nih.gov/pubmed/33910797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-240719 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|